+351 211 369 829 INFO@OPHIOMICS.COM

HepatoPredict presented at the ESA Meeting

Our collaborator from the Cento Hospital Universitário de Lisboa Central (Hospital Curry Cabral) presented an oral communication and discussed our work on predicting relapse after liver transplantation to treat hepatocellular carcinoma at the 28th anual meeting of the European Surgical Association. Lots of discussion and interest.

Share the Post:

Related Posts

Thinking Big!

Ophiomics is now participating in the IPOready program by Euronext. This is a great opportunity to consider the best strategy

Read More